Drug Delivery Without a Permanent Implant
In the evolving landscape of PCI, the focus is shifting from permanent metallic implants to vessel restoration strategies.
It combines:
• Excellent flexibility due to iGlide technology. This allows the balloon catheter to reach the target site with minimal loss of drug
• Excellent re-wrapability due to iTwin technology. Tight wrap and rewrap offers reduced friction, smaller profile and ease of withdrawal of the balloon catheter.
• Excellent deliverability due to iCoil technology. Easily navigate tortuous anatomy.
• Drug delivery with prolonged tissue residence time. This is possible because of iChem technology. Drug is eluted in two phases i) First phase (burst effect) ii) Second phase (reservoir effect)
Mural SEB is designed to deliver sirolimus drug effectively to the vessel wall while preserving native vessel anatomy — enabling treatment without leaving anything behind.
Key Features
Key Features
Proximal hypo-tube
Distal shaft coated with
for desired deliverability
Cutting edge balloon with for
Unique Formulation-Sirolimus + lipid formulation with
ground breaking i-Chem Technology ensuring rapid drug absorption
Stable drug formulation with controlled and targeted drug release
Drug concentration Sirolimus 3 µg/mm2
Soft, atraumatic tip with low entry profile
Large size matrix | Diameters – 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00 & 4.50 mm
Lengths – 9, 12, 14 15, 17, 20, 25, 30 , 33, 38 & 41 mm
Indication
- In-Stent Restenosis
- Small Vessel Disease
- De Novo Coronary Lesions
- Bifurcation lesions (Side Branch Strategy)
